Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Rheumatoid Arthritis Drugs
RA is a chronic inflammatory autoimmune disease seen in people aged between 30 and 60 years. The symptoms of the disease appear slowly, with mild pain around the joints coupled with stiffness and fatigue. In the later stages, it causes inflammation of the joints. Genetic and environmental elements are known to contribute to the development of the condition. DMARDs, NSAIDs, corticosteroids, and analgesics are being developed and administered to treat individuals with RA.
Technavio’s analysts forecast the global RA drugs market to grow at a CAGR of 3.43% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global RA drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat the disease.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Rheumatoid Arthritis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Amgen
• Bristol-Myers Squibb (BMS)
• Johnson & Johnson
• Pfizer
• F. Hoffmann-La Roche
Other prominent vendors
• Ablynx
• Alder BioPharmaceuticals
• Antares Medical Services
• Astellas Pharma
• AstraZeneca
• Boehringer Ingelheim
• Can-Fite BioPharma
• Celgene
• Celltrion
• ChemoCentryx
• Eisai
• Eli Lilly
• Gilead Sciences
• GlaxoSmithKline
• Incyte
• KaloBios Pharmaceuticals
• Lexicon Pharmaceuticals
• Merck
• Morphotek
• Novo Nordisk
• Regeneron Pharmaceuticals
• Sandoz
• Sanofi
• Santarus
• Takeda Pharmaceuticals
• UCB
• Vertex Pharmaceuticals
Market driver
• Growing older population
• For a full, detailed list, view our report
Market challenge
• Increasing costs of biologicals
• For a full, detailed list, view our report
Market trend
• Emergence of biosimilars
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
RA is a chronic inflammatory autoimmune disease seen in people aged between 30 and 60 years. The symptoms of the disease appear slowly, with mild pain around the joints coupled with stiffness and fatigue. In the later stages, it causes inflammation of the joints. Genetic and environmental elements are known to contribute to the development of the condition. DMARDs, NSAIDs, corticosteroids, and analgesics are being developed and administered to treat individuals with RA.
Technavio’s analysts forecast the global RA drugs market to grow at a CAGR of 3.43% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global RA drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat the disease.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Rheumatoid Arthritis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Amgen
• Bristol-Myers Squibb (BMS)
• Johnson & Johnson
• Pfizer
• F. Hoffmann-La Roche
Other prominent vendors
• Ablynx
• Alder BioPharmaceuticals
• Antares Medical Services
• Astellas Pharma
• AstraZeneca
• Boehringer Ingelheim
• Can-Fite BioPharma
• Celgene
• Celltrion
• ChemoCentryx
• Eisai
• Eli Lilly
• Gilead Sciences
• GlaxoSmithKline
• Incyte
• KaloBios Pharmaceuticals
• Lexicon Pharmaceuticals
• Merck
• Morphotek
• Novo Nordisk
• Regeneron Pharmaceuticals
• Sandoz
• Sanofi
• Santarus
• Takeda Pharmaceuticals
• UCB
• Vertex Pharmaceuticals
Market driver
• Growing older population
• For a full, detailed list, view our report
Market challenge
• Increasing costs of biologicals
• For a full, detailed list, view our report
Market trend
• Emergence of biosimilars
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
